Bridge City Capital, LLC - Q3 2020 holdings

$209 Million is the total value of Bridge City Capital, LLC's 91 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 60.0% .

 Value Shares↓ Weighting
HAE BuyHaemonetics Corporation$4,276,000
+17.7%
49,004
+20.8%
2.04%
+22.6%
IRBT BuyiRobot Corporation$3,141,000
-4.3%
41,381
+5.8%
1.50%
-0.4%
HCSG BuyHealthcare Services Group, Inc$3,103,000
+20.6%
144,141
+37.1%
1.48%
+25.6%
SUPN BuySupernus Pharmaceuticals Inc.$3,028,000
+3.0%
145,309
+17.4%
1.45%
+7.2%
CHRS NewCoherus Biosciences$2,182,000118,955
+100.0%
1.04%
CORT BuyCorcept Therapeutics Inc$1,963,000
+28.5%
112,798
+24.1%
0.94%
+33.7%
PLAB NewPhotronics$1,827,000183,441
+100.0%
0.87%
ZYXI NewZynex$1,796,000102,901
+100.0%
0.86%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Ensign Group, The26Q3 20233.0%
Methode Electronics, Inc.26Q3 20232.5%
US Physical Therapy Inc.26Q3 20232.5%
Tetra Tech, Inc.26Q3 20232.2%
Comfort Systems USA Inc.26Q3 20232.9%
Lithia Motors, Inc.26Q3 20232.1%
RBC Bearings Incorporated26Q3 20231.8%
Diodes Incorporated26Q3 20232.2%
MillerKnoll, Inc.26Q3 20232.1%
Globus Medical, Inc.26Q3 20231.7%

View Bridge City Capital, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-12
13F-HR2024-02-13
13F-HR2023-11-15
13F-HR2023-08-16
13F-HR2023-05-15
13F-HR2023-01-25
13F-HR2022-11-08
13F-HR2022-08-15
13F-HR2022-05-18
13F-HR2022-01-20

View Bridge City Capital, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (209423000.0 != 209426000.0)

Export Bridge City Capital, LLC's holdings